...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >FORMULATION AND STABILITY INDICATING ANALYSIS OF ORODISPERSIBLE TABLET OF PIROXICAM
【24h】

FORMULATION AND STABILITY INDICATING ANALYSIS OF ORODISPERSIBLE TABLET OF PIROXICAM

机译:吡咯昔康乳清片的配方及稳定性指示分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The main object of this research work is to develop and studying the stability analysis of orodispersible tablet of piroxicam. Five formulations of orodispersible tablets of piroxicam (F1-F4) were prepared using two different superdisintegrants namely crospovidone and sodium starch glycolate with two concentrations and a control F5 (without superdisintegrant) by direct term stability studies for the formulations showed no significant changes in disintegration compression method. The precompression and post compression study of piroxicam and excipient were carried out. The short time, drug content and percentage of drug released when stored at 4°C±2°C, 27°C ±2°C, and 45°C±2°C for 15 days.
机译:这项研究工作的主要目的是开发和研究吡罗昔康口服分散片的稳定性分析。吡罗昔康(F1-F4)口腔分散片的五种制剂是使用两种不同的超级崩解剂,即交联维酮和羟乙酸淀粉钠(两种浓度)和对照F5(无超级崩解剂)制备的,通过直接稳定性研究表明,崩解压缩无明显变化方法。进行了吡罗昔康和赋形剂的压缩前和压缩后研究。在4°C±2°C,27°C±2°C和45°C±2°C下保存15天后的短时间,药物含量和释放的百分比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号